Uncategorized
Valeant acquires Nicox Inc. for up to $20 million in cash, future payments
Valeant Pharmaceuticals has acquired Nicox’s U.S. diagnostics subsidiary Nicox Inc. in a deal totaling up to $20 million, Nicox announced in a press release.Under the terms of the agreement, Valeant acquired Nicox Inc. for $10 million in cash, plus additional cash payments of up to $10 million based on Valeant achieving sales benchmarks with transferred products. The deal is effective immediately.